Real Time Analysis of the Affinity Regulation of α4-Integrin
By A. Chigaev, A. M. Blenc, Julie V. Braaten, N. Kumaraswamy, C. Kepley, Ronald P. Andrews, J. Oliver, B. Edwards, E. Prossnitz, R. Larson and 1 more. Journal of Biological Chemistry, 2001
111 citations recorded by the source corpus.
This work examines the affinity of α4β1-integrin and whether affinity regulation by G protein-coupled receptor (GPCR) and chemokines receptors is compatible with cell adhesion mediated between α4-integrin and vascular cell adhesion molecule-1. We used flow cytometry to examine the binding of a fluorescent derivative of an LDV peptide (Chen, L. L., Whitty, A., Lobb, R. R., Adams, S. P., and Pepinsky, R. B. (1999)J. Biol. Chem. 274, 13167–13175) to several cell lines and leukocytes with α4-integrin ranging from about 2,000 to 100,000 sites/cell. The results support the idea that α4-integrins exhibit multiple affinities and that affinity changes are regulated by the dissociation rate and conformation. The affinity varies by 3 orders of magnitude with the affinity induced by binding mAb TS2/16 plus Mn2+ > Mn2+ ‘ TS2/16 > activation because of occupancy of GPCR or chemokines receptor > resting receptors. A significant fraction of the receptors respond to the activating process. The change in α4-integrin affinity and the corresponding change in off rates mediated by GPCR receptor activation are rapid and transient, and their duration depends on GPCR desensitization. The affinity changes mediated by IgE receptor or interleukin-5 receptor persist longer. It appears that the physiologically active state of the α4-integrin, determined by inside-out signaling, has similar affinity in several cell types.
Subfields: Immunology and Allergy, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/a068147059a2f7a0e21421bd2d4273d2f84846fd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Spencer
- D. Cain
- Charles P. Lin
- Roland Wohlgemuth
- Jasmeen S. Merzaban
- R. Sackstein
- N. Dagia
Citations in the corpus
- Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone (2008, background): “and stimulates integrin adhesiveness (for example, for VLA-4, VLA-5 and LFA-1) in human hematopoietic cells at concentrations far below those used in forced fucosylation (≤1 mM”